Inactivation of Foxo3a transcription is common in many tumors, including those of liver, breast, and prostate cancer (Barthel et al., 2005; Fukunaga et al., 2005; Zhang et al., 2017; Link, 2019). This evidence concerns the gene FOXO3 and Familial prostate cancer.